Latest news
Galaxy Therapeutics secures CE mark for embolisation system - Yahoo FinanceYahoo Finance · Tue, 04 Aug 2026 16:08:03 GMTNeurizon advances ALS trial in Q4 FY26 - The AustralianThe Australian · Tue, 04 Aug 2026 03:12:00 GMTNeurizon secures up to $17.5 million in non-dilutive R&D financing - BiotechDispatchBiotechDispatch · Mon, 03 Aug 2026 23:09:40 GMTLong Shortz: Neurizon Therapeutics - The AustralianThe Australian · Mon, 03 Aug 2026 23:07:00 GMTNeurizon Therapeutics Secures $17.5 Million Non-Dilutive R&D Funding Facility with Dare Capital - Kalkine MediaKalkine Media · Fri, 31 Jul 2026 07:00:00 GMTNeurizon Secures Up to $17.5 Million Non-Dilutive R&D Financing Facility with Dare Capital - KalkineKalkine · Fri, 31 Jul 2026 07:00:00 GMTNeurizon Completes 250-Participant HEALEY ALS Trial Enrolment and Secures $17.5M R&D Financing Facility - KalkineKalkine · Fri, 31 Jul 2026 07:00:00 GMTNeurizon (ASX:NUZ) Secures Funding for ALS Program Amid Leadership Refresh - KalkineKalkine · Wed, 29 Jul 2026 07:00:00 GMT